Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the Morgan Stanley 24th Annual Global Healthcare Conference in New York from September 14 to 16. (IMAGE)

InSilico Medicine

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the Morgan Stanley 24th Annual Global Healthcare Conference in New York from September 14 to 16.

Caption

On September 15 at 14:35 PM, he will participate in an in-person fireside chat, engaging in in-depth dialogue with global investors and industry leaders on the company's latest breakthroughs in generative AI-driven drug discovery, aging clocks, and anti-aging interventions.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.